LCN2 and central nervous system cancer: - SLC22A17/LCN2 are higher in glioma tissues but rarely present in non-neoplastic brain tissues (RNA and protein)- Overexpression of SLC22A17/LCN2 in glioma patients correlate with poor prognosis and low survival